59 related articles for article (PubMed ID: 3929815)
1. Event related evoked potentials in dementia.
Breeze RW
Br J Clin Pract Suppl; 1985 Jun; 39():43-4. PubMed ID: 3929815
[No Abstract] [Full Text] [Related]
2. Deapril-ST for senile dementia.
Med Lett Drugs Ther; 1977 Jul; 19(15):61-2. PubMed ID: 327247
[No Abstract] [Full Text] [Related]
3. [Comparison of subjective tolerance of hydergine specific and hydergine in gerontologic therapy].
Ronge J; Dennler HJ
Med Welt; 1982 Oct; 33(42):1485-9. PubMed ID: 6757638
[No Abstract] [Full Text] [Related]
4. Controlled study of dihydroergotoxine in gerontopsychiatric patients.
Slánská J
Act Nerv Super (Praha); 1989 Apr; 31(1):53-5. PubMed ID: 2782002
[No Abstract] [Full Text] [Related]
5. [A multicenter trial of treatment with slow-release dihydroergotoxine in chronic senile cerebral insufficiency].
Franchi F; Di Ruvo R; Guggino G; Mazzanti A; Genga A; Cucinotta D
G Clin Med; 1982 Jul; 63(7):465-81. PubMed ID: 6757035
[No Abstract] [Full Text] [Related]
6. [Can neurophysiologic tests differentiate between depression and dementia?].
Grapperon J; Bruschera D; Vidal F; Raoul Y
Ann Med Psychol (Paris); 1994 Apr; 152(4):217-28. PubMed ID: 8092661
[TBL] [Abstract][Full Text] [Related]
7. Design aspects of clinical trials with ergot alkaloids: a comparison of two geriatric behavioral rating scales.
Yesavage JA; Adey M
Adv Biochem Psychopharmacol; 1980; 23():357-62. PubMed ID: 7395622
[No Abstract] [Full Text] [Related]
8. Long-latency event-related potentials in normal aging and dementia.
Syndulko K; Hansch EC; Cohen SN; Pearce JW; Goldberg Z; Montan B; Tourtellotte WW; Potvin AR
Adv Neurol; 1982; 32():279-85. PubMed ID: 7054950
[No Abstract] [Full Text] [Related]
9. [Methodology of a controlled trial of dihydroergotoxine in acquired intellectual impairment in the adult].
Dartigues JF; Père JJ
Presse Med; 1983 Dec; 12(48):3173-5. PubMed ID: 6228936
[TBL] [Abstract][Full Text] [Related]
10. Review of clinical studies with ergots in gerontology.
Venn RD
Adv Biochem Psychopharmacol; 1980; 23():363-77. PubMed ID: 7395623
[No Abstract] [Full Text] [Related]
11. [Therapy of organic psychosyndrome with hydergine and digitalis. A component study using double blind technics].
Pfeiff E; Schlegel HE; Seus R; Dennler HJ; Kugler J
Med Welt; 1980 Sep; 31(39):1403-7. PubMed ID: 7005587
[No Abstract] [Full Text] [Related]
12. Auditory event-related potentials in Parkinson's disease: prominent correlation with attention.
Matsui H; Nishinaka K; Oda M; Kubori T; Udaka F
Parkinsonism Relat Disord; 2007 Oct; 13(7):394-8. PubMed ID: 17329143
[TBL] [Abstract][Full Text] [Related]
13. The clinical assessment of brain failure in the elderly.
McConnachie RW
Pharmacology; 1978; 16 Suppl 1():27-35. PubMed ID: 347464
[TBL] [Abstract][Full Text] [Related]
14. Auditory and visual event-related potentials in patients suffering from Alzheimer's dementia and multiinfarct dementia, before and after treatment with piracetam.
Dabic-Jeftic M; Mikula I
Funct Neurol; 1993; 8(5):335-45. PubMed ID: 8144060
[TBL] [Abstract][Full Text] [Related]
15. [Differences in P300 parameters, neuropsychological profile, and cognitive impairments in patients with cortical and subcortical dementia].
Revenok EV; Gnezditskiĭ VV; Kalashnikova LA
Fiziol Cheloveka; 2001; 27(3):42-53. PubMed ID: 11548425
[No Abstract] [Full Text] [Related]
16. Psychotropic drug induced changes in auditory averaged evoked potentials: results of a double-blind trial using an objective fully automated AEP analysis method.
Herrmann WM; Hofmann W; Kubicki S
Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):56-62. PubMed ID: 7216551
[No Abstract] [Full Text] [Related]
17. Evoked potentials in the assessment of brain function in senile dementia.
Laurian S; Gaillard JM; Wertheimer J
Adv Neurol; 1982; 32():287-93. PubMed ID: 7054951
[No Abstract] [Full Text] [Related]
18. Dihydroergotoxine: 6-mg versus 3-mg dosage in the treatment of senile dementia. Preliminary report.
Yesavage JA; Hollister LE; Burian E
J Am Geriatr Soc; 1979 Feb; 27(2):80-2. PubMed ID: 762369
[TBL] [Abstract][Full Text] [Related]
19. [Controlled double-blind study of the clinical equivalent of two posologic regimens of Hydergine: 1 x 4,5mg compared to 3 x 1,5mg per day].
Piguet PV; Zoufal Z
Rev Med Suisse Romande; 1981 Feb; 101(2):157-63. PubMed ID: 7015453
[No Abstract] [Full Text] [Related]
20. Electroencephalographic and clinical changes as correlated in geriatric patients treated three months with an ergot alkaloid preparation.
Matejcek M; Knor K; Piguet PV; Weil C
J Am Geriatr Soc; 1979 May; 27(5):198-202. PubMed ID: 372291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
